NIP
Nicholas Investment Partners’s Krystal Biotech KRYS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5,086
| Closed | -$797K | – | 217 |
|
2024
Q4 | $797K | Sell |
5,086
-13,721
| -73% | -$2.15M | 0.07% | 196 |
|
2024
Q3 | $3.42M | Buy |
18,807
+1,480
| +9% | +$269K | 0.31% | 124 |
|
2024
Q2 | $3.18M | Buy |
+17,327
| New | +$3.18M | 0.33% | 113 |
|
2024
Q1 | – | Sell |
-49,073
| Closed | -$6.09M | – | 215 |
|
2023
Q4 | $6.09M | Sell |
49,073
-306,538
| -86% | -$38M | 0.71% | 46 |
|
2023
Q3 | $41.3M | Sell |
355,611
-19,340
| -5% | -$2.24M | 3.08% | 2 |
|
2023
Q2 | $44M | Buy |
374,951
+233
| +0.1% | +$27.4K | 3.01% | 1 |
|
2023
Q1 | $30M | Buy |
374,718
+107,629
| +40% | +$8.62M | 2.28% | 4 |
|
2022
Q4 | $21.2M | Buy |
267,089
+45,063
| +20% | +$3.57M | 1.85% | 8 |
|
2022
Q3 | $15.5M | Sell |
222,026
-5,851
| -3% | -$408K | 1.43% | 17 |
|
2022
Q2 | $15M | Sell |
227,877
-855
| -0.4% | -$56.1K | 1.41% | 19 |
|
2022
Q1 | $15.2M | Buy |
228,732
+37,421
| +20% | +$2.49M | 1.08% | 28 |
|
2021
Q4 | $13.4M | Sell |
191,311
-65,564
| -26% | -$4.59M | 0.85% | 39 |
|
2021
Q3 | $13.4M | Sell |
256,875
-56,579
| -18% | -$2.95M | 0.98% | 30 |
|
2021
Q2 | $21.3M | Buy |
313,454
+8,765
| +3% | +$596K | 1.34% | 17 |
|
2021
Q1 | $23.5M | Buy |
304,689
+71,146
| +30% | +$5.48M | 1.64% | 8 |
|
2020
Q4 | $14M | Buy |
233,543
+11,121
| +5% | +$667K | 1.08% | 29 |
|
2020
Q3 | $9.58M | Buy |
222,422
+182,914
| +463% | +$7.87M | 1.04% | 34 |
|
2020
Q2 | $1.64M | Sell |
39,508
-42,408
| -52% | -$1.76M | 0.33% | 108 |
|
2020
Q1 | $3.54M | Buy |
81,916
+7,498
| +10% | +$324K | 0.69% | 54 |
|
2019
Q4 | $4.12M | Sell |
74,418
-35,409
| -32% | -$1.96M | 0.42% | 78 |
|
2019
Q3 | $3.81M | Sell |
109,827
-402
| -0.4% | -$14K | 0.32% | 122 |
|
2019
Q2 | $4.44M | Sell |
110,229
-996
| -0.9% | -$40.1K | 0.41% | 88 |
|
2019
Q1 | $3.66M | Sell |
111,225
-19,751
| -15% | -$650K | 0.33% | 104 |
|
2018
Q4 | $2.72M | Buy |
+130,976
| New | +$2.72M | 0.29% | 129 |
|